| Insurance Carrier | Facility/Professional | Modifier | Low Price | Median Price | High Price |
|---|---|---|---|---|---|
Aetna
| Professional | $450.00 | $450.00 | $450.00 | |
BCBS
| Facility | $460.80 | $460.80 | $460.80 | |
BCBS
| Professional | $460.80 | $460.80 | $460.80 | |
United
| Professional | $465.19 | $509.34 | $719.27 |
Intravenous infusion, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with COVID-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ECMO) only, includes infusion and post administration monitoring, second dose
| Insurance Carrier | Facility/Professional | Modifier | Low Price | Median Price | High Price |
|---|---|---|---|---|---|
Aetna
| Professional | $450.00 | $450.00 | $450.00 | |
BCBS
| Facility | $460.80 | $460.80 | $460.80 | |
BCBS
| Professional | $460.80 | $460.80 | $460.80 | |
United
| Professional | $465.19 | $509.34 | $719.27 |